Faster insulin may help teens with type 1 diabetes control blood sugar
NCT ID NCT06948760
First seen Mar 25, 2026 · Last updated May 14, 2026 · Updated 8 times
Summary
This study tested whether a faster-acting insulin (Lyumjev) works better than standard insulins (Humalog or Novolog) in an automated insulin pump system for teens with type 1 diabetes. Eleven adolescents aged 12 to 22 took part. Researchers used a special conversion factor to set up the pump for Lyumjev and measured how much time blood sugar stayed in a healthy range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia Center for Diabetes Technology
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.